IP Library Assignment 064144/0685
Patent Assignment
Reel/Frame 064144/0685

Assignee Change of Address

Recorded: 2023-06-27 Pages: 3
Assignor
CHEMOCENTRYX, INC.
Executed: 2023-06-23
Assignee
CHEMOCENTRYX, INC.
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320-1799
Covered Properties (35)
Aryl Sulfonamides
Patent: 6,939,885 →
Application: 10/716,170 →
Publication: US 2004/0171654
Aryl Sulfonamides
Patent: 7,420,055 →
Application: 10/846,241 →
Publication: US 2005/0137193
Bis-Aryl Sulfonamides
Patent: 7,227,035 →
Application: 10/848,836 →
Publication: US 2005/0137179
Aryl Sulfonamides
Patent: 7,932,252 →
Application: 11/596,147 →
Publication: US 2008/0161345
Triazolyl Phenyl Benzenesulfonamides
Patent: 7,718,683 →
Application: 11/775,585 →
Publication: US 2008/0039465
Triazolyl Pyridyl Benzenesulfonamides
Patent: 7,683,176 →
Application: 11/775,601 →
Publication: US 2008/0039504
Bis-Aryl Sulfonamides
Patent: 7,335,653 →
Application: 11/789,304 →
Publication: US 2007/0203131
N-(2-(Hetaryl)Aryl) Arylsulfonamides and N-(2-(Hetaryl) Hetaryl Arylsulfonamides
Patent: 7,776,877 →
Application: 12/140,593 →
Publication: US 2009/0005410
Triazolyl Pyridyl Benzenesulfonamides
Patent: 8,445,518 →
Application: 12/708,900 →
Publication: US 2010/0152186
Crystalline Form of the Sodium Salt of 4-Tert-Butyl-N-[4-Chloro-2-(1-Oxy-Pyridine-4-Carbonyl)-Phenyl]-Benzenesulfonamide
Patent: 9,133,124 →
Application: 13/554,169 →
Publication: US 2013/0059893
Aza-Aryl 1H-Pyrazol-1-Yl Benzene Sulfonamides
Patent: 8,916,601 →
Application: 13/781,412 →
Publication: US 2013/0225580
Polymorphic Forms of the Sodium Salt of 4-Tert-Butyl-N-[4-Chloro-2-(1-Oxy-Pyridine-4-Carbonyl)-Phenyl]-Benzenesulfonamide
Patent: 9,139,526 →
Application: 14/234,277 →
Publication: US 2014/0155438
Polymorphic Forms of the Sodium Salt of 4-Tert- Butyl -N-[4-Chloro-2-(1-Oxy-Pyridine-4-Carbonyl)-Phenyl]-Benzene Sulfonamide
Patent: 9,150,513 →
Application: 14/234,279 →
Publication: US 2014/0171473
Aza-Aryl 1H-Pyrazol-1-Yl Benzene Sulfonamides
Application: 14/541,637 →
Publication: US 2015/0073017
Aryl Sulfonamides
Patent: 9,890,148 →
Application: 14/551,438 →
Publication: US 2015/0080351
Polymorphic Forms of the Sodium Salt of 4-Tert-Butyl-N-[4-Chloro-2-(1-Oxy-Pyridine-4-Carbonyl)-Phenyl]-Benzenesulfonamide
Patent: 9,464,054 →
Application: 14/824,636 →
Publication: US 2016/0039762
Polymorphic Forms of the Sodium Salt of 4-Tert-Butyl-N-[4-Chloro-2-(1-Oxy-Pyridine-4-Carbonyl)-Phenyl]-Benzenesulfonamide
Patent: 9,493,417 →
Application: 14/832,755 →
Publication: US 2016/0039763
Compositions and Methods for Treating Inflammatory Bowel Disease Using a Combination Therapy of Small Molecule Inhibitors of C-C Chemokine Receptor 9 (CCR9) and Anti-alpha4beta7 Integrin Blocking Antibodies
Application: 14/875,506 →
Publication: US 2016/0095921
Polymorphic Forms of the Sodium Salt of 4-Tert- Butyl -N-[4-Chloro-2-(1-Oxy-Pyridine-4-Carbonyl)-Phenyl]-Benzene Sulfonamide
Patent: 9,809,548 →
Application: 15/289,629 →
Publication: US 2017/0022161
Immunomodulator Compounds
Application: 15/633,569 →
Publication: US 2018/0008554
Aryl Sulfonamides
Application: 15/697,414 →
Publication: US 2017/0369483
2-Oxindole Compounds
Application: 15/914,900 →
Publication: US 2019/0016709
Immunomodulator Compounds
Application: 16/047,545 →
Publication: US 2019/0135745
Macrocyclic Immunomodulators
Application: 16/057,077 →
Publication: US 2019/0048022
Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a Pd-1/Pd-L1 Inhibitor
Application: 16/139,745 →
Publication: US 2019/0134049
Aza-Aryl 1H-Pyrazol-1-Yl Benzene Sulfonamides
Application: 16/170,752 →
Publication: US 2019/0060304
Indane-Amines as Pd-L1 Antagonists
Application: 16/281,448 →
Publication: US 2019/0282555
Macrocyclic Immunomodulators
Application: 16/504,536 →
Publication: US 2020/0055869
2-Oxindole Compounds
Application: 16/524,618 →
Publication: US 2020/0123136
Compositions and Methods for Treating Inflammatory Bowel Disease Using a Combination Therapy of Small Molecule Inhibitors of C-C Chemokine Receptor Type 9 (CCR9) and Anti-ALPHA4BETA7 Integrin Blocking Antibodies
Application: 16/708,167 →
Publication: US 2020/0113898
Compositions and Methods for Treating Inflammatory Bowel Disease Using CCR9 Inhibitor and Anti-Tnf-Alpha Blocking Antibodies
Application: 16/740,861 →
Indane-Amines as Pd-L1 Antagonists
Application: 16/742,104 →
Publication: US 2020/0375962
Immunomodulator Compounds
Application: 16/751,019 →
Publication: US 2021/0052514
Triaryl Compounds for Treatment of Pd-L1 Diseases
Application: 16/874,212 →
Publication: US 2020/0383979
2-Oxindole Compounds
Application: 16/932,114 →
Publication: US 2021/0101890
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 22, 2004
From: UGASHE, SOLOMON; WEI, ZHENG; WRIGHT, J.J.; PENNELL, ANDREW
To: CHEMOCENTRYX
Reel/Frame 015252/0240 →
Assignment of Assignor's Interest Nov 1, 2004
From: UNGASHE, SOLOMON; WRIGHT, J.J.; PENNELL, ANDREW; WEI, ZHENG
To: CHEMOCENTRYX
Reel/Frame 015944/0061 →
Assignment of Assignor's Interest Nov 15, 2004
From: UNGASHE, SOLOMON; WEI, ZHENG; WRIGHT, J.J.; PENNELL, ANDREW
To: CHEMOCENTRYX
Reel/Frame 015988/0143 →
To Correct the First and Third Assignor Name and Record a Change of Address of the Assignee on Assignment Document Per Recorded on Reel/Frame 015252/0240. Jul 8, 2005
From: UNGASHE, SOLOMON; WEI, ZHENG; WRIGHT, JOHN J.; PENNELL, ANDREW
To: CHEMOCENTRYX, INC.
Reel/Frame 016496/0720 →
Corrective Assignment to Correct the First and Third Names of the Conveying Party, Along with the Address of the Assignee Previously Recorded at Reel 015252 Frame 0240. the Conveying Partys' Hereby Confirm the Assignment of the Assignee. Jul 8, 2005
From: UNGASHE, SOLOMON; WEI, ZHENG; WRIGHT, JOHN J.; PENNELL, ANDREW
To: CHEMOCENTRYX, INC.
Reel/Frame 016848/0218 →
Record to Correct the Second and Fifth Assignor Names on Assignment Document Per Recorded on Reel/Frame 015944/0061. Jul 8, 2005
From: UNGASHE, SOLOMON; WRIGHT, JOHN J.; PENNELL, ANDREW; WEI, ZHENG
To: CHEMOCENTRYX, INC.
Reel/Frame 016505/0640 →
Correct the First and Third Assignor Names, and Record a Change of Address of the Assignee on Reel/Frame 015252/0240 Sep 15, 2005
From: UNGASHE, SOLOMON; WEI, ZHENG; WRIGHT, JOHN J.; PENNELL, ANDREW
To: CHEMO CENTRYX, INC.
Reel/Frame 016804/0506 →
Corrective Assignment to Correct the 3RD Assignor's Name Previously Recorded at Reel 015988 Frame 0143. Assignor Confirms the Assignment. Nov 7, 2005
From: UNGASHE, SOLOMON; WEI, ZHENG; WRIGHT, JOHN J.; PENNELL, ANDREW
To: CHEMOCENTRYX, INC.
Reel/Frame 017004/0157 →
Assignment of Assignor's Interest Apr 23, 2007
From: UNGASHE, SOLOMON; WEI, ZHENG; WRIGHT, JOHN J.; PENNELL, ANDREW
To: CHEMOCENTRYX
Reel/Frame 019292/0235 →
Assignment of Assignor's Interest Oct 31, 2007
From: CHARVAT, TREVOR T.; HU, CHENG; JIN, JEFF; LI, YANDONG
To: CHEMOCENTRYX, INC.
Reel/Frame 020040/0137 →
Assignment of Assignor's Interest Oct 31, 2007
From: CHARVAT, TREVOR T.; HU, CHENG; MELIKIAN, ANITA; NOVACK, AARON
To: CHEMOCENTRYX, INC.
Reel/Frame 020040/0124 →
Assignment of Assignor's Interest Nov 8, 2007
From: UNGASHE, SOLOMON; WRIGHT, JOHN JESSEN; PENNELL, ANDREW
To: CHEMOCENTRYX, INC.
Reel/Frame 020086/0873 →
Assignment of Assignor's Interest Dec 9, 2009
From: CHARVAT, TREVOR T.; HU, CHENG; MELIKIAN, ANITA; NOVACK, AARON
To: CHEMOCENTRYX, INC.
Reel/Frame 023624/0908 →
Assignment of Assignor's Interest Feb 19, 2010
From: CHARVAT, TEVOR T.; HU, CHENG; JIN, JEFF; LI, YANDONG
To: CHEMOCENTRYX, INC.
Reel/Frame 023962/0791 →
Assignment of Assignor's Interest Nov 1, 2012
From: PENNELL, ANDREW M.K.
To: CHEMOCENTRYX, INC.
Reel/Frame 029228/0796 →
Assignment of Assignor's Interest Nov 13, 2014
From: CHEN, XI; FAN, JUNFA; FAN, PINGCHEN; KRASINSKI, ANTONI
To: CHEMOCENTRYX, INC.
Reel/Frame 034167/0615 →
Assignment of Assignor's Interest May 22, 2015
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: CHEMOCENTRYX, INC.
Reel/Frame 035699/0915 →
Assignment of Assignor's Interest May 22, 2015
From: BIS, JOANNA; IGO, DAVID H.; SHAH, DEVEN
To: GLAXO GROUP LIMITED
Reel/Frame 035697/0477 →
Assignment of Assignor's Interest May 22, 2015
From: HO, BERT
To: CHEMOCENTRYX, INC.
Reel/Frame 035697/0483 →
Assignment of Assignor's Interest May 22, 2015
From: GLAXO GROUP LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 035697/0631 →
Assignment of Assignor's Interest May 22, 2015
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: CHEMOCENTRYX, INC.
Reel/Frame 035697/0810 →
Assignment of Assignor's Interest May 22, 2015
From: BIS, JOANNA; IGO, DAVID H.
To: GLAXO GROUP LIMITED
Reel/Frame 035699/0216 →
Assignment of Assignor's Interest May 22, 2015
From: GLAXO GROUP LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 035699/0510 →
Assignment of Assignor's Interest Sep 14, 2017
From: UNGASHE, SOLOMON; WRIGHT, JOHN J.; PENNELL, ANDREW; WEI, ZHENG
To: CHEMOCENTRYX, INC.
Reel/Frame 043586/0393 →
Assignment of Assignor's Interest Dec 28, 2017
From: HO, BERT
To: CHEMOCENTRYX, INC.
Reel/Frame 044499/0680 →